{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:02:07Z","timestamp":1787929327431,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","award":["97U-340"],"award-info":[{"award-number":["97U-340"]}],"id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e28053","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T20:28:55Z","timestamp":1710966535000},"page":"e28053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Circulating afamin positively correlated with the miR-122 expression and type 2 diabetes mellitus-related phenotype according to the duration of diabetes"],"prefix":"10.1016","volume":"10","author":[{"given":"Abnoos","family":"Mokhtari Ardekani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Kharazinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7809-2732","authenticated-orcid":false,"given":"Hassan","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahmatollah","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e28053_bib1","first-page":"69","article-title":"Association of afamin concentration with type 1 and type 2 diabetes mellitus","volume":"33","author":"Ali","year":"2021","journal-title":"Zanco Journal of Pure and Applied Sciences"},{"key":"10.1016\/j.heliyon.2024.e28053_bib2","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1016\/S0021-9258(17)32429-8","article-title":"Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family","volume":"269","author":"Lichenstein","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e28053_bib3","doi-asserted-by":"crossref","first-page":"14532","DOI":"10.1021\/bi026513v","article-title":"Characterization of the vitamin E-binding properties of human plasma afamin","volume":"41","author":"Voegele","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2024.e28053_bib4","series-title":"Ageing and Dementia Current and Future Concepts","first-page":"337","article-title":"Vitamin E binding protein A famin protects neuronal cells in vitro","author":"Heiser","year":"2002"},{"key":"10.1016\/j.heliyon.2024.e28053_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/pr0500105","article-title":"Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression","volume":"4","author":"Jerkovic","year":"2005","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.heliyon.2024.e28053_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1471-4159.2008.05796.x","article-title":"Afamin is synthesized by cerebrovascular endothelial cells and mediates \u03b1\u2010tocopherol transport across an in vitro model of the blood\u2013brain barrier","volume":"108","author":"Kratzer","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.heliyon.2024.e28053_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bone.2012.06.015","article-title":"Afamin secreted from nonresorbing osteoclasts acts as a chemokine for preosteoblasts via the Akt-signaling pathway","volume":"51","author":"Kim","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.heliyon.2024.e28053_bib8","first-page":"822","article-title":"Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome","volume":"7","author":"Kronenberg","year":"2014","journal-title":"Circulation: cardiovascular genetics"},{"key":"10.1016\/j.heliyon.2024.e28053_bib9","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2337\/dc17-0201","article-title":"Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: a pooled analysis in more than 20,000 individuals","volume":"40","author":"Kollerits","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.heliyon.2024.e28053_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-018-0338-x","article-title":"Is afamin a novel biomarker for gestational diabetes mellitus? A pilot study","volume":"16","author":"K\u00f6ninger","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e28053_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1530\/EC-19-0064","article-title":"Afamin predicts gestational diabetes in polycystic ovary syndrome patients preconceptionally","volume":"8","author":"K\u00f6ninger","year":"2019","journal-title":"Endocrine connections"},{"key":"10.1016\/j.heliyon.2024.e28053_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214457","article-title":"First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus","volume":"14","author":"Ravnsborg","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e28053_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00404-018-4897-z","article-title":"Afamin: an early predictor of preeclampsia","volume":"298","author":"K\u00f6ninger","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.heliyon.2024.e28053_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cca.2017.11.031","article-title":"First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women","volume":"476","author":"Tramontana","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2024.e28053_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cca.2013.08.016","article-title":"Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma","volume":"425","author":"Dieplinger","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.heliyon.2024.e28053_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature07242","article-title":"The impact of microRNAs on protein output","volume":"455","author":"Baek","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e28053_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e28053_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1566523214666141224095610","article-title":"miR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir","volume":"15","author":"Thakral","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.heliyon.2024.e28053_bib19","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2014.10.004","article-title":"miR-122\u2013a key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e28053_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/ATVBAHA.112.300144","article-title":"MicroRNAs in metabolic disease","volume":"33","author":"Fern\u00e1ndez-Hernando","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.heliyon.2024.e28053_bib21","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1093\/eurheartj\/ehw146","article-title":"Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?","volume":"37","author":"Willeit","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2024.e28053_bib22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates","volume":"452","author":"Elm\u00e9n","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e28053_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2024.e28053_bib24","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e28053_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db16-0731","article-title":"Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes","volume":"66","author":"Willeit","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.heliyon.2024.e28053_bib26","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.heliyon.2024.e28053_bib27","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1194\/jlr.D300007-JLR200","article-title":"A novel and simple method for quantification of small, dense LDL","volume":"44","author":"Hirano","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.heliyon.2024.e28053_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/1354750X.2021.1928754","article-title":"Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: a systematic review and meta-analysis","volume":"26","author":"Cai","year":"2021","journal-title":"Biomarkers"},{"key":"10.1016\/j.heliyon.2024.e28053_bib29","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1007\/s12011-020-02559-0","article-title":"The role of afamin and other trace elements in the prediction of GDM: a tertiary center experience","volume":"199","author":"Ero\u011flu","year":"2021","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.heliyon.2024.e28053_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413378","article-title":"Transient hyperglycemia and hypoxia induce memory effects in AngiomiR expression profiles of feto-placental endothelial cells","volume":"22","author":"Strutz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e28053_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1540201","article-title":"Single nucleotide polymorphisms in mir-122 are associated with the risk of hepatocellular carcinoma in a southern Chinese population","volume":"2018","author":"Bei","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.heliyon.2024.e28053_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.670425","article-title":"Serum afamin a novel marker of increased hepatic lipid content","volume":"12","author":"Kurdiova","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e28053_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7175108","article-title":"Association between serum afamin levels with nonalcoholic associated fatty liver disease","volume":"2022","author":"Chen","year":"2022","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"key":"10.1016\/j.heliyon.2024.e28053_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/dna.2010.1097","article-title":"The mouse alpha-albumin (afamin) promoter is differentially regulated by hepatocyte nuclear factor 1\u03b1 and hepatocyte nuclear factor 1\u03b2","volume":"30","author":"Liu","year":"2011","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e28053_bib35","doi-asserted-by":"crossref","DOI":"10.26444\/aaem\/92650","article-title":"Afamin and adropin in patients with alcohol-induced liver cirrhosis","volume":"25","author":"Prystupa","year":"2018","journal-title":"Ann. Agric. Environ. Med."},{"key":"10.1016\/j.heliyon.2024.e28053_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0065-230X(08)60523-0","article-title":"Alpha-fetoprotein in ontogenesis and its association with malignant tumors","volume":"14","author":"Abelev","year":"1971","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e28053_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0304-3835(00)00589-9","article-title":"Significant down-regulation of alpha-albumin in human hepatoma and its implication","volume":"160","author":"Wu","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e28053_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mce.2016.06.013","article-title":"Afamin promotes glucose metabolism in papillary thyroid carcinoma","volume":"434","author":"Shen","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.heliyon.2024.e28053_bib39","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s11010-021-04086-5","article-title":"Role of Wnt signaling pathways in type 2 diabetes mellitus","volume":"476","author":"Chen","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2024.e28053_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nutres.2018.06.009","article-title":"The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome","volume":"70","author":"Abou Ziki","year":"2019","journal-title":"Nutr. Res. (N.Y.)"},{"key":"10.1016\/j.heliyon.2024.e28053_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1479164117738442","article-title":"Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases","volume":"15","author":"Ackers","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.heliyon.2024.e28053_bib42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.21608\/ebwhj.2022.167998.1213","article-title":"High serum levels of afamin and tumor necrosis factor-\u03b1 during the first trimester might be used as early predictors for gestational diabetes mellitus in euglycemic pregnant women","volume":"12","author":"Bendary","year":"2022","journal-title":"Evidence Based Women's Health Journal"},{"key":"10.1016\/j.heliyon.2024.e28053_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2018.02.034","article-title":"Urinary afamin levels are associated with the progression of diabetic nephropathy","volume":"147","author":"Kaburagi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.heliyon.2024.e28053_bib44","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1007\/s11033-023-08344-1","article-title":"miR-122 dysregulation is associated with type 2 diabetes mellitus-induced dyslipidemia and hyperglycemia independently of its rs17669 variant","volume":"50","author":"Mokhtari Ardekani","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2024.e28053_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.118452","article-title":"Associations of plasma metal levels with type 2 diabetes and the mediating effects of microRNAs","volume":"292","author":"Nie","year":"2022","journal-title":"Environ. Pollut."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024040842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024040842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:16:08Z","timestamp":1784207768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024040842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024040842"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28053","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating afamin positively correlated with the miR-122 expression and type 2 diabetes mellitus-related phenotype according to the duration of diabetes","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e28053"}}